Newsletter
Last Door's recovery bid
On June 12, Last Door Recovery Society issued a statement in response to the charges laid against a longtime employee or contractor at the facility. To many, it felt like gaslighting.
Newsletter
On June 12, Last Door Recovery Society issued a statement in response to the charges laid against a longtime employee or contractor at the facility. To many, it felt like gaslighting.
Newsletter
The abstinence-only recovery centre that harboured an alleged abuser for a decade has an office in Calgary, a lucrative contract with the UCP and local nonprofit sponsors. Alberta should cut ties.
Newsletter
There won't be any silver linings for those unable to access regulated supply, supervised consumption or appropriate housing options under the new UCP government.
Newsletter
We won't get updated mortality counts before the election, but EMS and supervised consumption data tell us the situation is bad as ever.
Newsletter
Framing drug toxicity as a tool of land occupation can guide settlers to reposition their grief from individual tragedies to collateral damage of genocidal policy.
Newsletter
Conflicts of interest, prison guards and police stand between health care providers and their patients in Alberta's Virtual Opioid Dependency Program.
Newsletter
Many credit the premier's chief of staff as the architect of the "Alberta Model," but who's the engine? Let's have a look at friends of the UCP from here to California.
Newsletter
Police are connecting people in detainment with opioid agonist treatments. How does this interfere with prescriber-patient relationships?
Newsletter
A reported "cover-up" by Calgary Police and its civilian commission exposes questionable practices in mental wellness with Christian undercurrents
Newsletter
A presentation I delivered to Calgary City Council during budget hearings in November, 2022.
Newsletter
Why do we allow police chiefs to steer political decisions then sweep up the winnings?
Newsletter
The UCP make frequent use of a small network of real and fake academics to simulate rigour on regressive drug policy. This time, they brought in Dr. Keith Humphreys.